Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples